A Phase IIIB Study to Compare the Efficacy and Safety of Concomitant Treatment in Patients With COPD

Summary

The purpose of this study is to evaluate the safety and efficacy of the concomitant treatment of formoterol fumarate with tiotropium bromide compared to treatment with tiotropium bromide alone.

Timeline

Start

2006-04

Primary completion

2006-05

Completion

2006-12

Publications

• Results Tashkin DP, Littner M, Andrews CP, Tomlinson L, Rinehart M, Denis-Mize K. Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: a placebo-controlled trial. Respir Med. 2008 Apr;102(4):479-87. doi: 10.1016/j.rmed.2007.12.019. Epub 2008 Feb 6.

Drugs

Indications